The Genting-backed neurodegenerative disease treatment developer has disclosed it raised $71m through a rights issue in October.
Month: March 2018
BugCrowd sources $26m in series C
Salesforce Ventures returned for a round that increased the crowdsourced cybersecurity platform’s overall funding to $50m.
Cullgen collects up to $15m from GNI
US-based drug discovery platform developer Cullgen has secured a seed commitment of up to $15m from life sciences research and development firm GNI Group. Cullgen is developing a drug discovery platform that works by stopping deterioration in the ubiquitin-proteasome system, a process responsible for cell growth, migration, signalling and death. The company will initially concentrate… Continue reading Cullgen collects up to $15m from GNI
Sony and KDDI enter Tier IV
The corporates contributed to a $28.4m round and will look to work with Tier IV to test its autonomous driving software.
S&P calculates $550m Kensho acquisition
S&P Global has agreed to acquire portfolio company Kensho, an AI-equipped information software provider, in a deal that will also allow GV to exit.
Capital G gets on UiPath for $153m round
US-based task automation software provider UiPath secured $153m yesterday in a series B round featuring CapitalG, a subsidiary of internet and technology group Alphabet, at a $1.1bn valuation. The round was led by Accel and included fellow venture capital firms Kleiner Perkins Caufield & Byers, Credo Ventures and Earlybird, the latter investing through its Digital… Continue reading Capital G gets on UiPath for $153m round
Giga trades Experian for Ericsson
Asif Giga has taken an investment director position at Ericsson Ventures having come from another corporate venturing unit, Experian Ventures.
PharmEasy takes care in $30m series C
Manipal Education and Medical Group has participated in a round that took the total raised by the healthcare product and access platform to $53m.
First Access to entertain startups
First Access Entertainment has turned to angel investor Simon Tikhman for a fund that will invest in businesses with the potential to satisfy the youth demographic.
Edgybees captures seed funding
Motorola Solutions Venture Capital and Verizon Ventures helped the augmented reality video software developer secure $5.5m.
Homology to hone $100m IPO
Rare disease therapy developer Homology Medicines has raised approximately $130m in VC funding from investors including Novartis.
NAB helps cement BrickX’s $7m series A
Australia-based property investment platform BrickX has secured A$9m ($7m) in a series A round backed by NAB Ventures, the corporate venturing arm of banking group National Australia Bank (NAB). The contribution adds to an undisclosed amount of series A funding supplied by Reinventure, the venture capital firm sponsored by another of Australia’s ‘big four’ banks, Westpac,… Continue reading NAB helps cement BrickX’s $7m series A
Vividion vivifies $101m partnership
Celgene has paid biotech startup Vividion $101m up front in a strategic partnership that includes an equity investment of undisclosed size.
Kr Space to expand with new funding
The co-working space provider, spun out from 36Kr, is set to use the $94.7m it has raised to add 300,000 square metres of office space by the end of 2018.